Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 15/20 | 0.61 |
| ▸ | EGFR | P00533 | 1/20 | 0.48 |
| ▸ | KDR | P35968 | 16/20 | 0.45 |
| ▸ | RET | P07949 | 3/20 | 0.43 |
| ▸ | KIF5B | P33176 | 2/20 | 0.43 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.39 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3280052 | 0.84 | SRC (0.67) | SRCEGFRKDRRETKIF5B | |
| SCHEMBL6922194 | 0.84 | SRC (0.75) | SRCEGFRKDR | |
| SCHEMBL6819711 | 0.84 | SRC (0.72) | SRCEGFRKDR | |
| SCHEMBL6829839 | 0.82 | SRC (0.60) | SRCEGFRKDRRETKIF5B | |
| SCHEMBL6826353 | 0.82 | SRC (0.60) | SRCEGFRKDRMKNK1MKNK2 | |
| SCHEMBL6831400 | 0.82 | SRC (0.64) | SRCEGFRKDRRETKIF5B | |
| SCHEMBL6819634 | 0.82 | SRC (0.61) | SRCEGFRKDRMKNK1MKNK2 | |
| SCHEMBL6823529 | 0.81 | SRC (0.62) | SRCEGFRKDR | |
| SCHEMBL6823799 | 0.79 | EGFR (0.52) | SRCEGFRKDRRETKIF5B | |
| SCHEMBL6823949 | 0.76 | SRC (0.77) | SRCKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004056812-A1 | 4- (PYRIDIN-4-YLAMINO) -QUINAZOLINE DERIVATIVES AS ANTI-TUMOR AGENTS | ASTRAZENECA AB (SE) | 2004-07-08 | — | — | WO | disclosed |